Search

Author/Creator Frieri, Camilla

1. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. Issue 5 (May 2021)

Authors:
Risitano, Antonio M; Röth, Alexander; Soret, Juliette; Frieri, Camilla; de Fontbrune, Flore Sicre; Marano, Luana; Alashkar, Ferras; Benajiba, Lina; Marotta, Serena; Rozenberg, Izabela; Milojevic, Julie; End, Peter; Nidamarthy, Prasanna K; Junge, Guido; Peffault de Latour, Régis
Journal:
Lancet
Issue:
Volume 8:Issue 5(2021)
Page Start:
e344
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia. (22nd May 2020)

Authors:
Cesini, Laura; Frieri, Camilla; Baratè, Claudia; Sorà, Federica; Bonifacio, Massimiliano; Cerrano, Marco; Cagnetta, Antonia; Elena, Chiara; Aprile, Lara; Sgherza, Nicola; Trawinska, Malgorzata; Gozzini, Antonella; Capodanno, Isabella; Crugnola, Monica; Carmosino, Ida; Scalzulli, Emilia; Ricci, Fe...
Journal:
European journal of haematology
Issue:
Volume 105:Number 3(2020)
Page Start:
286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗